Preparation of icariside II from icariin by enzymatic hydrolysis method

Fitoterapia

Volumn 81, Issue 5, 2010, Pages 437-442

  Xia, Quan ^a   Xu, Dujuan ^a   Huang, Zhaogang ^a   Liu, Jianjun ^a   Wang, Xinqun ^a   Wang, Xiu ^a   Liu, Shangquan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Enzymatic hydrolysis; Herba Epimedii; Icariin; Icariside II

Indexed keywords

BETA GLUCOSIDASE; ICARIIN; ICARISIDE II; UNCLASSIFIED DRUG;

ARTICLE; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; EPIMEDIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; REACTION OPTIMIZATION; SPECTROSCOPY;

BERBERIDACEAE; BETA-GLUCOSIDASE; DRUG COMPOUNDING; FLAVONOIDS; HYDROLYSIS; MOLECULAR STRUCTURE;

EID: 77954217199     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2009.12.006     Document Type: Article

References (11)

1. China Pharmacopoeia Committee, Pharmacopoeia of the people's Republic of China, Chemical Industry Press, Beijing, China, Vol.1, 2005, p. 229.
2. J. Huang, L. Yuan, X. Wang, T.L. Zhang, and K. Wang Icariin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro Life Sci 81 2007 832 840
3. F.H. Meng, Z.L. Xiong, Z.M. Jiang, and F.M. Li Osteoblastic proliferation stimulating activity of epimedium koreanum nakai extracts and its flavonol glycosides Pharm Biol 43 2005 92 95
4. Y.W. Zhang, I. Morita, G. Shao, X.S. Yao, and S. Murota Screening of anti-hypoxia/reoxygenation agents by an in vitro model. Part 1: natural inhibitors for protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells Planta Med 66 2000 114 118
5. Y.W. Zhang, I. Morita, L. Zhang, G. Shao, X.S. Yao, and S. Murota Screening of anti-hypoxia/reoxygenation agents by an in vitro method. Part 2: inhibition of tyrosine kinase activation prevented hypoxia/reoxygenation-induced injury in endothelial gap junctional intercellular communication Planta Med 66 2000 119 123
6. 2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells Cancer Lett 280 2009 93 100
7. J.S. Park, H.Y. Park, H.S. Rho, S. Ahn, D.H. Kim, and L.S. Chang Statistically designed enzymatic hydrolysis for optimized production of icariside II as a novel melanogenesis inhibitor J Microbiol Biotechnol 18 2008 110 117
8. H.J. Choi, J.S. Eun, D.K. Kim, R.H. Li, T.Y. Shin, and H. Park Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1alpha in human osteosarcoma cells Eur J Pharmacol 579 2008 58 65
9. X.J. Chen, H. Ji, Q.W. Zhang, P.F. Tu, Y.T. Wang, and B.L. Guo A rapid method for simultaneous determination of 15 flavonoids in Epimedium using pressurized liquid extraction and ultra-performance liquid chromatography J Pharm Biomed Anal 46 2008 226 235
10. R. Liu, A.F. Li, A.L. Sun, J.C. Cui, and L.Y. Kong Preparative isolation and purification of three flavonoids from the Chinese medicinal plant Epimedium koreamum Nakai by high-speed counter-current chromatography J Chromatogr A 1064 2005 53 57 (Pubitemid 40126580)
11. T. Fukai, and T. Nomura Seven prenylated flavonol glycosides from two epimedium species Phytochemistry 27 1988 259 266